Next-Gen Anti-Inflammatory Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories
Discover trends, market shifts, and competitive outlooks for the anti-inflammatory therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Fast Is The Anti-Inflammatory Therapeutics Market Expected to Grow Between 2025 And 2029?
In the past years, the size of the anti-inflammatory therapeutics market has continually increased. It’s forecasted to expand from $114.71 billion in 2024 to $118.44 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.3%. Factors contributing to this growth during the historical period include the surge in chronic diseases, an aging population, higher levels of awareness, and government efforts.
Predictions show a robust expansion in the anti-inflammatory therapeutics market in the coming years. The market is anticipated to reach a size of $144.05 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%. Key drivers for this prospective growth during the forecast period include innovative treatments, heightened healthcare spending, attention to rare diseases, and the development of biologics and biosimilars. Trending advancements in the same period are expected to include progress in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in medicinal discovery, and an increase in indications.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anti-Inflammatory Therapeutics Market?
The escalating incidence of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market. As a long-term ailment that leads to the inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) is significantly managed with the aid of anti-inflammatory therapeutics. These therapeutics are instrumental in mitigating inflammation, handling the symptoms, and reducing the probability of surgery in patients with Crohn’s disease. For instance, Oxford University Press (OUP), which is the university press for the University of Oxford, reported in July 2023 that the incidence rate of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years, and the prevalence rate is 721 per 100,000 individuals. Hence, the escalating incidence of inflammatory bowel disease significantly contributes to the growth of the anti-inflammatory therapeutics market. The Anti-Inflammatory Therapeutics Market is greatly influenced by the prevalence of Autoimmune Disorder, and the surge in this prevalence is predicted to foster robust growth in the same market. The continuous rise in the frequency of autoimmune disorders is also predicted to strongly boost the expansion of the anti-inflammatory therapeutics market. Autoimmune disorders refer to a series of health conditions where the immune system wrongly targets and attacks the body’s own healthy cells and tissues instead of harmful invaders such as bacteria and viruses. The continuous rise of autoimmune disorders significantly impacts the growth of anti-inflammatory therapeutics. Such therapeutics are widely used in treating autoimmune disorders by aiming to lessen inflammation, curb the overactive response of the immune system and ease the symptoms associated with these conditions. For example, reports published by the UK-based Guardian Media Group in January 2022 project that 4 million individuals in the UK will be affected by autoimmune disorders, and it is estimated that this number will increase globally by 3% to 9% every year. Moreover, according to the University of Oxford, another UK-based research university, autoimmune disorders were impacting 10% of the global population by May 2023. Hence, the continuous rise in the frequency of autoimmune disorders significantly contributes to the growth of the anti-inflammatory therapeutics market.
Which Key Market Segments Comprise the Anti-Inflammatory Therapeutics Market and Drive Its Revenue Growth?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp
Which Areas Are Leading Regions in the Anti-Inflammatory Therapeutics Market Expansion Across the Globe?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Key Market Trends in the Anti-Inflammatory Therapeutics Market Over the Coming Years?
Main businesses in the market for anti-inflammatory treatments are launching novel drugs in an effort to solidify their market standings. As an example, in February 2023, the American biotech entity, Regeneron Pharmaceuticals Inc., and Sanofi, a French pharmaceutical and healthcare enterprise, introduced Kevzara (sarilumab). This is the inaugural and sole anti-inflammatory biologic suggested for matured patients suffering from polymyalgia rheumatic (PMR), an inflammation-related rheumatic condition. It’s specifically catered to those unresponsive to corticosteroids or those who cannot tolerate corticosteroid tapering.
View the full report here:
How Is the Anti-Inflammatory Therapeutics Market Conceptually Defined?
Anti-inflammatory therapeutics refer to prescription medications that treat pain, lessen inflammation, and lower a high body temperature. It acts as a host response modifier and plays a crucial role in managing acute and chronic headaches, painful phases, sprains, and strain problems.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
